undamentalytics Newsletter
Sign in

ASP Isotopes Inc. income statement

In fiscal 2025, ASP Isotopes Inc. reported revenue of $23.8m, up 475.5% on the year before, operating income of −$59.9m (a -251.2% margin) and net income of −$160m, or −$2.11 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0042431
Cost of revenue0032025
Gross profit00236
Research and development1131222
General and administrative415254880
Operating income−5−16−26−60−99
Interest expense00014
Net interest income0————
Income before tax−5−16−32−160−137
Income tax0−0000
Net income−5−16−32−160−117
Diluted EPS—−$0.49−$0.63−$2.11−$1.08
Diluted shares (average)27m33m56m83m108m
EBITDA−5−16−26−58−94

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ASPI vs CNEYASPI vs TANHASPI vs BONASPI vs PMA

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from ASP Isotopes Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to ASP Isotopes Inc.